158 related articles for article (PubMed ID: 27416572)
21. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
Lee WP; Datta BN; Ong BB; Rees A; Halcox J
Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
[TBL] [Abstract][Full Text] [Related]
22. Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group.
Daida H; Lee YJ; Yokoi H; Kanoh T; Ishiwata S; Kato K; Nishikawa H; Takatsu F; Kato H; Kutsumi Y
Am J Cardiol; 1994 Jun; 73(15):1037-40. PubMed ID: 8198026
[TBL] [Abstract][Full Text] [Related]
23. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
Geiss HC; Otto C; Parhofer KG
Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435
[TBL] [Abstract][Full Text] [Related]
24. Treatment of homozygous familial hypercholesterolemia with low density lipoprotein apheresis: a 4 year follow-up study.
Fadul JE; Vessby B; Wikström B; Danielson BG
Artif Organs; 1997 May; 21(5):364-8. PubMed ID: 9129767
[TBL] [Abstract][Full Text] [Related]
25. Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia.
Kolovou G; Diakoumakou O; Kolovou V; Fountas E; Stratakis S; Zacharis E; Liberopoulos EN; Matsouka F; Tsoutsinos A; Mastorakou I; Katsikas T; Mavrogeni S; Hatzigeorgiou G
Eur J Prev Cardiol; 2020 Jan; 27(2):157-165. PubMed ID: 31403880
[TBL] [Abstract][Full Text] [Related]
26. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.
Richter WO; Donner MG; Höfling B; Schwandt P
Metabolism; 1998 Jul; 47(7):863-8. PubMed ID: 9667236
[TBL] [Abstract][Full Text] [Related]
27. Lipoprotein apheresis of hypercholesterolemic patients mediates vasoprotective gene expression in human endothelial cells.
Morawietz H; Goettsch W; Brux M; Reimann M; Bornstein SR; Julius U; Ziemssen T
Atheroscler Suppl; 2013 Jan; 14(1):107-13. PubMed ID: 23357151
[TBL] [Abstract][Full Text] [Related]
28. The Italian Registry for Therapeutic Apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology.
Passalacqua S; Staffolani E; Busnach G; Roccatello D; Pasquali S; Cappelli P; Liuzzo G;
J Clin Apher; 2005 Jul; 20(2):101-6. PubMed ID: 15880354
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of a new whole-blood low-density lipoprotein apheresis system (Liposorber D) in severe hypercholesterolemia.
Otto C; Kern P; Bambauer R; Kallert S; Schwandt P; Parhofer KG
Artif Organs; 2003 Dec; 27(12):1116-22. PubMed ID: 14678426
[TBL] [Abstract][Full Text] [Related]
30. Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.
Kroon AA; van Asten WN; Stalenhoef AF
Ann Intern Med; 1996 Dec; 125(12):945-54. PubMed ID: 8967704
[TBL] [Abstract][Full Text] [Related]
31. Flaxseed (
Kanikowska D; Korybalska K; Mickiewicz A; Rutkowski R; Kuchta A; Sato M; Kreft E; Fijałkowski M; Gruchała M; Jankowski M; Bręborowicz A; Witowski J
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32325781
[TBL] [Abstract][Full Text] [Related]
32. Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a).
Stefanutti C; Pisciotta L; Favari E; Di Giacomo S; Vacondio F; Zenti MG; Morozzi C; Berretti D; Mesce D; Vitale M; Pasta A; Ronca A; Garuti A; Manfredini M; Anglés-Cano E; Marcovina SM; Watts GF;
J Clin Lipidol; 2020; 14(4):487-497.e1. PubMed ID: 32718857
[TBL] [Abstract][Full Text] [Related]
33. Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS).
Aengevaeren WR; Kroon AA; Stalenhoef AF; Uijen GJ; van der Werf T
J Am Coll Cardiol; 1996 Dec; 28(7):1696-704. PubMed ID: 8962554
[TBL] [Abstract][Full Text] [Related]
34. Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a).
Safarova MS; Moriarty PM
Curr Atheroscler Rep; 2023 Jul; 25(7):391-404. PubMed ID: 37273067
[TBL] [Abstract][Full Text] [Related]
35. Direct adsorption of lipoproteins from whole blood by direct adsorption of lipoprotein apheresis: first experience in two hypercholesterolemic children.
Bayrakci US; Besbas N; Ozcebe O; Coskun T; Akgul E; Kutluk T; Bakkaloglu A
Ther Apher Dial; 2005 Dec; 9(6):469-72. PubMed ID: 16354278
[TBL] [Abstract][Full Text] [Related]
36. Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group.
Gordon BR; Kelsey SF; Dau PC; Gotto AM; Graham K; Illingworth DR; Isaacsohn J; Jones PH; Leitman SF; Saal SD; Stein EA; Stern TN; Troendle A; Zwiener RJ
Am J Cardiol; 1998 Feb; 81(4):407-11. PubMed ID: 9485128
[TBL] [Abstract][Full Text] [Related]
37. Lipoprotein turnover and possible remnant accumulation in preeclampsia: insights from the Freiburg Preeclampsia H.E.L.P.-apheresis study.
Contini C; Jansen M; König B; Markfeld-Erol F; Kunze M; Zschiedrich S; Massing U; Merfort I; Prömpeler H; Pecks U; Winkler K; Pütz G
Lipids Health Dis; 2018 Mar; 17(1):49. PubMed ID: 29540222
[TBL] [Abstract][Full Text] [Related]
38. Just not cosmesis! Role of low-density lipoprotein apheresis in familial hypercholesterolemia: Experience at a newly developed tertiary care institution in Northern India.
Kaur D; Negi G; Walia R; Malhotra S; Bhatia R; Meinia SK; Mandal S; Jain A
Asian J Transfus Sci; 2021; 15(1):104-108. PubMed ID: 34349468
[TBL] [Abstract][Full Text] [Related]
39. Toward an international consensus-Integrating lipoprotein apheresis and new lipid-lowering drugs.
Stefanutti C; Julius U; Watts GF; Harada-Shiba M; Cossu M; Schettler VJ; De Silvestro G; Soran H; Van Lennep JR; Pisciotta L; Klör HU; Widhalm K; Moriarty PM;
J Clin Lipidol; 2017; 11(4):858-871.e3. PubMed ID: 28572002
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
